undamentalytics Newsletter
Sign in

Clover Health Investments, Corp. income statement

In fiscal 2025, Clover Health Investments, Corp. reported revenue of $1.92bn, up 40.3% on the year before, operating income of −$85.5m (a -4.4% margin) and net income of −$85.5m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue4626731,4721,0971,2611,3711,9242,477
Gross profit——−7970257———
General and administrative96121185204183176214260
Operating income−183−93−637−287−205−46−86−18
Interest expense233631000—
Income before tax————−213−43−86—
Income tax0000000—
Net income−364−136−588−340−213−43−86−18
Diluted EPS−$4.14−$1.54−$1.42−$0.71−$0.44——−$0.03
Diluted shares (average)88m89m413m476m482m490m512m530m
EBITDA−186−93−637−288−209−48−87−18

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ALHC vs CLOVCLOV vs OSCRCLOV vs MOH

More: Managed Health Care stocks compared, Health Care sector, rankings of US companies

Figures from Clover Health Investments, Corp.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Clover Health Investments, Corp.